RICCIO, GENNARO
 Distribuzione geografica
Continente #
NA - Nord America 538
EU - Europa 292
AS - Asia 267
AF - Africa 7
SA - Sud America 2
Totale 1.106
Nazione #
US - Stati Uniti d'America 529
IT - Italia 129
SG - Singapore 111
CN - Cina 76
HK - Hong Kong 57
FI - Finlandia 29
IE - Irlanda 29
RU - Federazione Russa 24
DE - Germania 22
NL - Olanda 19
SE - Svezia 19
GB - Regno Unito 11
VN - Vietnam 10
CA - Canada 9
CI - Costa d'Avorio 7
IN - India 6
KR - Corea 3
AT - Austria 2
BR - Brasile 2
ES - Italia 2
IR - Iran 2
JP - Giappone 2
BE - Belgio 1
CH - Svizzera 1
FR - Francia 1
GR - Grecia 1
RS - Serbia 1
UA - Ucraina 1
Totale 1.106
Città #
Chandler 106
Singapore 70
Hong Kong 57
Santa Clara 41
Napoli 26
Princeton 25
Millbury 22
Nanjing 20
Ashburn 19
Boston 18
Amsterdam 17
Naples 17
Des Moines 12
Beijing 11
Wilmington 11
Dong Ket 10
Jacksonville 9
Ottawa 9
Perugia 9
Nanchang 8
Helsinki 7
Jiaxing 7
Pune 6
Boardman 5
Seattle 5
Shenyang 5
Acerra 4
Falkenstein 4
Kunming 4
Falls Church 3
Hangzhou 3
Rome 3
Washington 3
Ann Arbor 2
Bagheria 2
Hwaseong-si 2
Kronberg 2
Lanzhou 2
Lawrence 2
Milan 2
Munich 2
Phoenix 2
Pontecagnano 2
Redwood City 2
Tokyo 2
Turin 2
Zhengzhou 2
Anacapri 1
Aversa 1
Bath 1
Belgrade 1
Camerino 1
Caserta 1
Changchun 1
Changsha 1
Council Bluffs 1
Curti 1
Dallas 1
Dublin 1
Frankfurt am Main 1
Gondomar 1
Greenwich 1
Hanover 1
Hebei 1
Houston 1
Indiana 1
Kaifeng 1
Kraainem 1
Kwangju 1
Los Angeles 1
Miami 1
New York 1
Nocera Inferiore 1
Norwalk 1
Ourinhos 1
Sandston 1
Shanghai 1
Solopaca 1
Tianjin 1
Valencia 1
Vallo della Lucania 1
Vienna 1
Vila Velha 1
Xi'an 1
Xiaogan 1
Yantai 1
Yonkers 1
Zurich 1
Totale 645
Nome #
A Boost in Mitochondrial Activity Underpins the Cholesterol-Lowering Effect of Annurca Apple Polyphenols on Hepatic Cells 84
A Negative Allosteric Modulator of WNT Receptor Frizzled 4 Switches into an Allosteric Agonist. 70
Ranolazine attenuates trastuzumab-induced heart dysfunction by modulating ROS production 66
Novel Human Anti-ErbB2 Immunoagents 55
One-Step Recovery of scFv Clones from High-Throughput Sequencing-Based Screening of Phage Display Libraries Challenged to Cells Expressing Native Claudin-1 52
Fusion protein comprising three binding domains to HER2 52
Novel Human Anti-ErbB2 Immunoagents 45
Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors. 44
Mechanisms of cardiotoxicity associated with ErbB2 inhibitors. 44
A novel fully human antitumor ImmunoRNase resistant to the RNase inhibitor. 44
Anti-ErbB2 immunoagents 42
A Novel Human Anti-tumor Dimeric ImmunoRNase 40
Anti-ErbB2 Human Immunoagents 39
Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies? 39
Cardioprotection induced by ranolazine after trastuzumab treatment: the reduction of cardiotoxicity in vitro and in vivo study 39
T-cell Activating Tribodies as a Novel Approach for Efficient Killing of ErbB2-positive Cancer Cells. 39
Inhibition of cardiomyocytes late I-Na with ranolazine blunts anthracyclines-cardiotoxicity in experimental models in vitro and in vivo 38
Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents 36
Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents 36
Effects of a human compact anti-ErbB2 antibody on gastric cancer. 34
Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells 34
RANOLAZINE AT THE END OF TRASTUZUMAB THERAPY PREVENTS LEFT VENTRICULAR DYSFUNCTION: IN VITRO AND IN VIVO STUDY 34
NOVEL HUMAN ANTI-ErbB2 IMMUNOAGENTS 32
First and Second Generation Human anti-ErbB2 Immunoagents 29
Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of Ranolazine 29
Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors 28
Novel human anti-ErbB2 immunoagents 22
Totale 1.146
Categoria #
all - tutte 5.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.262


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026 0 0 0 0 0 0 0 2 0 3 13 8
2020/202173 6 0 11 2 4 16 3 4 4 4 5 14
2021/2022173 2 0 0 1 0 4 4 6 32 4 60 60
2022/2023238 37 15 14 16 39 30 3 12 34 19 9 10
2023/2024138 7 26 25 11 6 17 1 11 0 2 21 11
2024/2025282 32 41 2 5 29 51 84 38 0 0 0 0
Totale 1.146